RAL vs ECG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 13, 2026

RAL

32.3
AI Score
VS
ECG Wins

ECG

39.1
AI Score

Investment Advisor Scores

RAL

32score
Recommendation
AVOID NEW MONEY

ECG

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric RAL ECG Winner
Forward P/E 21.692 19.2308 ECG
PEG Ratio 0 0 Tie
Revenue Growth 12.8% 33.7% ECG
Earnings Growth 21.4% 59.2% ECG
Tradestie Score 32.3/100 39.1/100 ECG
Profit Margin -56.4% 6.0% ECG
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

RAL 1M: +0.4% · 3M: -1.5% ECG 1M: -8.8% · 3M: -23.2%

Current Technical Phase

RAL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.8 · Price: $69.29

ECG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.5%), weak momentum, RSI 33

RSI (14): 33.2 · Price: $106.00

Fundamentals Snapshot

Metric RAL ECG
Market Cap — —
Forward P/E 20.5 16.9
Trailing P/E — 21.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.3%
Gross Margin 0.5% 0.1%
Operating Margin 0.1% 0.1%
EPS -10.93 4.83
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, ECG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.